肌肉减少症及其单项标准部分与血液透析患者死亡率相关
在645例来自旧金山和亚特兰大的 prevalent 血液透析患者中,利用透析前生物阻抗光谱测量全身肌肉量,评估肌肉减少症(低肌肉量)四种指数化方法、握力弱和步速慢与死亡率的关联;平均随访1.9年观察到78例死亡。校正协变量后,肌肉减少症及任何肌肉量标准均与死亡率无显著关联,而握力弱或步速慢与死亡率相关;仅步速慢显著提高死亡预测准确性(C统计量从0.63升至0.68)。
要点
- 校正协变量后,肌肉减少症及任何肌肉量标准均与死亡率无显著关联。
- 握力弱或步速慢与死亡率相关,且步速慢显著提高死亡预测准确性。
- 步速慢和握力弱的净重分类指数显著优于无功能测量模型,肌肉量模型则无此优势。
核心结论
- 在血液透析患者中,肌肉减少症或低肌肉量本身并不比单纯功能受限更好地预测死亡率。
- 包括步速慢和握力弱在内的身体功能测量与死亡率相关,即使校正肌肉量和其他混杂因素后仍相关。
研究设计与样本
- 研究纳入645例来自旧金山和亚特兰大的ACTIVE/ADIPOSE队列中的 prevalent 血液透析患者。
- 采用透析前生物阻抗光谱测量全身肌肉量。
- 低肌肉量定义为低于NHANES年轻成人性别特异性均值两个标准差,并以身高平方、体重、体表面积或体重指数进行指数化。
主要发现
- 平均随访1.9年期间观察到78例死亡。
- 校正协变量后,肌肉减少症与死亡率无显著关联。
- 无论采用何种指数化指标,任何肌肉量标准均与死亡无关联。
- 校正模型中,握力弱或步速慢与死亡率相关。
- 仅步速慢显著提高死亡预测准确性,C统计量从0.63升至0.68。
关键数值与推荐
- 低肌肉量定义为低于NHANES年轻成人性别特异性均值两个标准差。
- 肌肉量指数化方法包括身高平方、体重、体表面积或体重指数。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The relative importance of sarcopenia and its individual components as independent predictors of mortality in the dialysis population has not been determined. We estimated whole-body muscle mass using pre-dialysis bioimpedance spectroscopy measurements in 645 ACTIVE/ADIPOSE-enrolled prevalent hemodialysis patients from San Francisco and Atlanta. Low muscle mass was defined as two standard deviations below sex-specific means for young adults from NHANES and indexed to height2, body weight, body surface area, or body mass index. We evaluated the association of sarcopenia (low muscle mass) by four indexing methods, weak hand grip strength, and slow gait speed with mortality. Seventy-eight deaths were observed during a mean follow-up of 1.9 years. Sarcopenia was not significantly associated with mortality after adjusting for covariates. No muscle mass criteria were associated with death, regardless of indexing metrics. In contrast, having weak grip strength or slow walking speed was associated with mortality in the adjusted model. Only gait slowness significantly improved the predictive accuracy for death with an increase in C-statistic from 0.63 to 0.68. However, both gait slowness and hand grip weakness significantly improved the net reclassification index compared to models without performance measures (50.5% for slowness and 33.7% for weakness), whereas models with muscle size did not. Neither sarcopenia nor low muscle mass by itself was a better predictor of mortality than functional limitation alone in patients receiving hemodialysis. Thus, physical performance measures, including slow gait speed and weak hand grip strength, were associated with mortality even after adjustment for muscle size and other confounders.
引用
- Kittiskulnam P, Chertow GM, Carrero JJ, et al. Sarcopenia and its individual criteria are associated, in part, with mortality among patients on hemodialysis. Kidney Int. 2017. PMID: 28318630. doi:10.1016/j.kint.2017.01.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。